Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 68Neoplasms 25Breast Neoplasms 15Squamous Cell Carcinoma of Head and Neck 13Lung Neoplasms 12Head and Neck Neoplasms 11Neoplasm Metastasis 8Carcinoma, Squamous Cell 7Pancreatic Neoplasms 6Colorectal Neoplasms 6Stomach Neoplasms 5Esophageal Squamous Cell Carcinoma 5Prostatic Neoplasms 4Multiple Myeloma 4Esophageal Neoplasms 4Lymphoma 3Hematologic Neoplasms 3Glioblastoma 3Brain Neoplasms 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Solid Tumors 2Non-small-cell Lung Cancer With Somatic EGFR Mutations 2NSCLC 2Melanoma 2Glioma 2Colonic Neoplasms 2Adenocarcinoma of Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1

Interventions

Vincristine 2Temozolomide 2Oncolytic Virotherapy 2vorasidenib 1repotrectinib 1pralsetinib 1pembrolizumab 1pamiparib 1lutetium Lu 177 dotatate 1interferon gamma-1b 1copper dotatate CU-64 1cixutumumab 1Vorinostat 1Valproic Acid 1Thiotepa 1Sunitinib 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1ONC206 1Melphalan 1Maintenance Chemotherapy 1Lutetium-177 1Lutetium 1Lomustine 1Interleukin-12 1Interferon-gamma 1Immunotherapy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Afatinib × Clear all
NCT02372006 2021-03-04

Trial of Afatinib in Pediatric Tumours

Boehringer Ingelheim

Phase 1/2 Completed
56 enrolled 23 charts
Sarcoma

Rhabdomyosarcoma, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡